№ 4/2019

№ 4/2019

 

 

 

 

 

 

 

 

LYMPHOID TUMORS

Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

Kaplanov KD, Volkov NP, Klitochenko TYu, Matveeva IV, Shipaeva AL, Shirokova MN, Davydova NV, Gemdzhian EG

PDF

pdficon

Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

Firsova MV, Mendeleeva LP, Kovrigina AM, Solov’ev MV, Deineko NL, Drokov MYu, Savchenko VG

PDF

pdficon

Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma

Samarina SV, Luchinin AS, Minaeva NV, Paramonov IV, D’yakonov DA, Vaneeva EV, Rosin VA, Gritsaev SV

PDF

pdficon

MYELOID TUMORS

Current Genetic Models for Prediction of Primary Myelofibrosis

Polushkina LB, Shuvaev VA, Fominykh MS, Krivolapov YuA, Belyakova EA, Asaulenko ZP, Motyko EV, Martynenko LS, Bakai MP, Tsybakova NYu, Voloshin SV, Bessmeltsev SS, Chechetkin AV, Martynkevich IS

PDF

pdficon

Cerebrovascular Disorders Associated with Ph-Negative Myeloproliferative Diseases

Tanashyan MM, Kuznetsova PI, Melikyan AL, Raskurazhev AA

PDF

pdficon

BONE MARROW TRANSPLANTATION

Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

Osipov YuS, Bessmeltsev SS, Salogub GN, Ivanov VV, Mikhailov ES, Zhukova NA, Chechetkin AV

PDF

pdficon

EXPERIMENTAL STUDIES

Heme Oxygenase-1/Ferritin in Protection of Leukemia Cells from Oxidative Stress Induced by Catalytic System “Teraphtal + Ascorbic Acid

Sidorova TA, Ryabaya OO, Prokof’eva AA, Khochenkov DA

PDF

pdficon

RARE HEMATOLOGICAL TUMORS AND SYNDROMES

Diagnosis of EBV-Associated Inflammatory Pseudotumor in the Spleen: A Case Report

Chebotarev DI, Kovrigina AM, Korzhova SM, Danishyan KI, Sabirov KR

PDF

pdficon

 

A Case of M-Paraprotein-Associated Polyneuropathy with Stable Response to Rituximab Therapy

Potapenko VG, Kiselev VN

PDF

pdficon

 

ANTINEOPLASTIC THERAPY COMPLICATIONS

Infections in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib: Incidence and Predisposing Factors

Dmitrieva EA, Nikitin EA, Markova EE, Dmitrieva NYu, Ptushkin VV

PDF

pdficon

 

Antithrombotic Therapy in Patients with Malignant Lymphoproliferative Disorders Treated with Ibrutinib

Emelina EI, Gendlin GE, Nikitin IG

PDF

pdficon

 

Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia

Dubinina YuN, Sarzhevskii VO, Melnichenko VYa

PDF

pdficon

 

CONGRESSES, CONFERENCES, SYMPOSIA

Materials of the 45th Congress of the European Society for Blood and Marrow Transplantation (March, 2019; Frankfurt am Main)

Melkova KN, Sharoyan ZhV

PDF

pdficon